[
  {
    "ts": null,
    "headline": "Johnson & Johnson, Boston Scientific to Headline MEDevice Boston 2025 Keynote Sessions",
    "summary": "BOSTON, MA / ACCESS Newswire / September 23, 2025 / MEDevice Boston , the premier MedTech event connecting top OEMs (Original Equipment Manufacturers) with emerging suppliers and strategic partners, has announced its lineup of distinguished keynote ...",
    "url": "https://finnhub.io/api/news?id=9b8ebb4cc3677d20360b87342c05c1c433361ad4284ebb3c1fc05cc12b85d2cf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758636000,
      "headline": "Johnson & Johnson, Boston Scientific to Headline MEDevice Boston 2025 Keynote Sessions",
      "id": 136850402,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BOSTON, MA / ACCESS Newswire / September 23, 2025 / MEDevice Boston , the premier MedTech event connecting top OEMs (Original Equipment Manufacturers) with emerging suppliers and strategic partners, has announced its lineup of distinguished keynote ...",
      "url": "https://finnhub.io/api/news?id=9b8ebb4cc3677d20360b87342c05c1c433361ad4284ebb3c1fc05cc12b85d2cf"
    }
  },
  {
    "ts": null,
    "headline": "Does Boston Scientific’s Recent Dip Signal Opportunity After NEuwave Expansion in 2025?",
    "summary": "If you’re on the fence about what to do with Boston Scientific stock, you’re not alone. Plenty of investors are taking a hard look at the recent numbers and wondering whether this is a moment to buy in or sit tight. Over the past month, shares have dipped 8.6%, giving back some of the impressive gains racked up over the last few years. However, taking a broader view reveals a stock that is up more than 150% over both three and five years, with an 8.6% gain year to date and a 15.5% jump over...",
    "url": "https://finnhub.io/api/news?id=ecc1c4116151e27c7505c52da965f4b9671ef3b24a0a43313b5aba4d3f39c9c6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758625667,
      "headline": "Does Boston Scientific’s Recent Dip Signal Opportunity After NEuwave Expansion in 2025?",
      "id": 136850944,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "If you’re on the fence about what to do with Boston Scientific stock, you’re not alone. Plenty of investors are taking a hard look at the recent numbers and wondering whether this is a moment to buy in or sit tight. Over the past month, shares have dipped 8.6%, giving back some of the impressive gains racked up over the last few years. However, taking a broader view reveals a stock that is up more than 150% over both three and five years, with an 8.6% gain year to date and a 15.5% jump over...",
      "url": "https://finnhub.io/api/news?id=ecc1c4116151e27c7505c52da965f4b9671ef3b24a0a43313b5aba4d3f39c9c6"
    }
  }
]